April 8, 2021 | Digital, Lucid, Medical Communications, technology, virtual congresses

In this month’s PME, Jonathan Andrew, Technology Director at Lucid Group discusses the digital transformation that swept through the medcomms industry due to the COVID-19 pandemic. In particular, we saw the entire pharmaceutical congress scene turned on its head as the world went into lockdown, bringing face-to-face gatherings to an abrupt halt. The congress organisers, pharma firms and their logistics/creative med-comms agencies rallied at speed to adjust to the new normal of running events virtually, and still managed to still put on an excellent show.
Twelve months on, we now have a year’s worth of learnings and engagement metrics to reflect on; but what, if anything, has changed? What might ‘good’ look like, considering the insight?
In this article, Jonathan reflects on the key learnings which will help to shape the delivery of a new hybrid approach to post-pandemic medical meetings and congresses.
“By attempting to create a like-for-like congress environment – complete with 3D-virtual exhibition halls and 3D-virtual booths, we have inadvertently broken what makes an online experience great, and subsequently made content much harder for delegates to locate and interact with.”
You can access and download the full article here.
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Appointment marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. Lucid’s US Medical Affairs division unveils new proprietary insights…
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid…
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced…
In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the…
In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines…
Meet our talent team, they’re here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your…
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so…
Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on…
